CCRA Awardees for 2019 Announced
The CCRA biennial awards recognize individuals who have made a remarkable impact on cancer research and the cancer research community. We are pleased to announce the five 2019 awardees:
- Mr. Patrick Sullivan for Exceptional Leadership in Patient Involvement in Cancer Research
- Dr. Anne-Marie Mes-Masson for Exceptional Leadership in Cancer Research
- Dr. Gerald Batist for Exceptional Leadership in Cancer Research
- Dr. Lincoln Stein for Outstanding Achievements in Cancer Research
- Dr. Geoffrey Fong for Distinguished Service to Cancer Research
The awards will be presented at the Canadian Cancer Research Conference (CCRC) on Monday November 4, 2019 at the Shaw Centre in Ottawa. For more on awardees, click here.
Accelerating the Commercialization of Cancer Research Results
The Canadian Cancer Society (CCS) and the Creative Destruction Lab (CDL) have launched a new world-class accelerator program for entrepreneurs and researchers developing innovations to improve the cancer experience globally and throughout the cancer care continuum. This program will educate, coach, finance and inspire seed-stage oncology-focused companies by pairing them with mentors, industry leaders and subject matter experts. Over 9 months and 5 sessions, accepted startups will be supporte... Read More »
Investment in Cancer Research in 2022
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research inve... Read More »
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research inve... Read More »